These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 26582057

  • 1. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
    Cao W, Li F, Yao J, Yu J.
    BMC Cancer; 2015 Nov 18; 15():915. PubMed ID: 26582057
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.
    Weng J, Wang J, Cai Y, Stafford LJ, Mitchell D, Ittmann M, Liu M.
    Int J Cancer; 2005 Feb 20; 113(5):811-8. PubMed ID: 15499628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y, Li Q, Li D, Gu J, Qian D, Qin X, Chen Y.
    Life Sci; 2021 Jan 01; 264():118638. PubMed ID: 33164833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
    Barbisan F, Mazzucchelli R, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montorsi F, Montironi R.
    Eur Urol; 2009 Jul 01; 56(1):105-12. PubMed ID: 18468781
    [Abstract] [Full Text] [Related]

  • 10. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C, Bubendorf L, Ruiz C, Zlobec I, Bachmann A, Heberer M, Spagnoli GC, Wyler S, Mengus C.
    Eur J Cancer; 2013 Mar 01; 49(4):955-63. PubMed ID: 23089465
    [Abstract] [Full Text] [Related]

  • 11. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG, Gardner WA.
    Med Hypotheses; 2008 Mar 01; 70(2):387-408. PubMed ID: 17658698
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
    Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL.
    Clin Cancer Res; 2002 Aug 01; 8(8):2541-52. PubMed ID: 12171882
    [Abstract] [Full Text] [Related]

  • 18. Expression of store-operated channel components in prostate cancer: the prognostic paradox.
    Perrouin Verbe MA, Bruyere F, Rozet F, Vandier C, Fromont G.
    Hum Pathol; 2016 Mar 01; 49():77-82. PubMed ID: 26826413
    [Abstract] [Full Text] [Related]

  • 19. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
    Rigau M, Morote J, Mir MC, Ballesteros C, Ortega I, Sanchez A, Colás E, Garcia M, Ruiz A, Abal M, Planas J, Reventós J, Doll A.
    Prostate; 2010 Dec 01; 70(16):1760-7. PubMed ID: 20672322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.